The effect of adding oral dexamethasone to feed alterations on the airway cell inflammatory gene expression in stabled horses affected with recurrent airway obstruction

Journal of Veterinary Internal Medicine

Volumn 22, Issue 2, 2008, Pages 427-435

  DeLuca, L ^a   Erb, H N ^a   Young, J C ^a   Perkins, G A ^a   Ainsworth, D M ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Chemokine (C X C motif) ligand 2; Interleukin 1 receptor 2; Interleukin 1 ; Interleukin 8; Pelleted feed; Toll like receptor 4

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; DEXAMETHASONE;

ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ANIMAL HOUSING; ARTICLE; BIOSYNTHESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HORSE; HORSE DISEASE; INFLAMMATION; LUNG LAVAGE; MALE; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

ANIMAL FEED; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CROSS-OVER STUDIES; DEXAMETHASONE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; HOUSING, ANIMAL; INFLAMMATION; LUNG DISEASES, OBSTRUCTIVE; MALE;

ANIMALIA; EQUIDAE;

EID: 42449125298     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0055.x     Document Type: Article

References (47)

1. McPherson EA, Thomson JR. Chronic obstructive pulmonary disease in the horse. I. Nature of the disease. Equine Vet J 1983;15:203-206.
2. Pirie RS, Dixon PM, McGorum BC. Endotoxin contamination contributes to the pulmonary inflammatory and functional response to Aspergillus fumigatus extract inhalation in "heaves" horses. Clin Exp Allergy 2003;33:1289-1296.
3. Von Essen SG, Robbins RA, Thompson AB, et al. Mechanisms of neutrophil recruitment to the lung by grain dust exposure. Am Rev Respir Dis 1998;1389:921-927.
4. Derksen FJ, Scott JS, Miller DC, et al. Bronchoalveolar lavage in ponies with recurrent airway obstruction (heaves). Am Rev Respir Dis 1985;132:1066-1070.
5. Derksen FJ, Robinson NE, Armstrong PJ, et al. Airway reactivity in ponies with recurrent airway obstruction (heaves). J Appl Physiol 1985;58:584-604.
6. Vandenput S, Votion D, Duvivier DH, et al. Effect of a set stabled environmental control on and airway reactivity of COPD affected horses. Vet J 1998;155:189-195.
7. Vandenput S, Duvivier DH, Votion D, et al. Environmental control to maintain stabled COPD horses in clinical remission: Effects on. Equine Vet J 1998;30:93-96.
8. Ammann VJ, Vrins AA, Lavoie J-P. Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J 1998;30:152-157.
9. Robinson NE, Jackson C, Jefcoat A, et al. Efficacy of three corticosteroids for the treatment of heaves. Equine Vet J 2002;34:17-22.
10. Cornelisse CJ, Robinson NE, Berney CEA, et al. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Equine Vet J 2004;36:426-430.
11. Couroucé-Malblanc A, Fortier G, Pronost S, et al. Comparison of prednisolone and dexamethasone effects in the presence of environmental control in heaves-affected horses. Vet J 2008; doi: 10.1016/j.tvjl.2006.12.006.
12. Giguère S, Viel L, Lee E, et al. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet Immunol Immunopathol 2002;85:147-158.
13. Couëtil LL, Art T, de Moffarts B, et al. Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. J Vet Intern Med 2006;20:399-406.
14. Franchini M, Gilli U, von Fellenberg R, et al. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res 2000;61:1369-1374.
15. Ainsworth DM, Grünig G, Matychak MB, et al. Recurrent airway obstruction (RAO) in horses is characterized by IFN-γ and IL-8 production in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2003;96:83-91.
16. Ainsworth DM, Wagner B, Franchini M, et al. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am J Vet Res 2006;67:669-677.
17. Deetz DC, Jagielo PJ, Quinn TJ, et al. The kinetics of grain dust-induced inflammation of the lower respiratory tract. Am J Respir Crit Care Med 1997;155:254-259.
18. Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-κB in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 2000;161:1314-1321.
19. Bureau F, Delhalle S, Bonizzi G, et al. Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma. J Immunol 2000;165:5822-5830.
20. Couëtil LL, Art T, de Moffarts B, et al. DNA binding activity of transcription factors in bronchial cells of horses with recurrent airway obstruction. Vet Immunol Immunopathol 2006;113:11-20.
21. Mambula SS, Sau K, Henneke P, et al. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002;277;39320-39326.
22. Meier A, Kirschning CJ, Nikolaus T, et al. Toll-like receptor (TLR)2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003;5:561-570.
23. Braedel S, Radsak M, Einsele H, et al. Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptors 2 and 4. Br J Haemat 2004;125:392-399.
24. Chase MA, Wheeler DS, Lierl KM, et al. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through TLR4 and NF(kappa)B-dependent mechanisms. J Immunol 2007;179:6318-6324.
25. Berndt A, Derksen FJ, Venta PJ, et al. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am J Physiol Lung Cell Mol Physiol 2007;292:L936-L943.
26. Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 2004;4:378-385.
27. Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol 2004;28:415-428.
28. Barnes PJ. Corticosteroids: The drugs to beat. Eur J Pharm 2006;533:2-14.
29. Ehrchen J, Steinmüller L, Barczyk K, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007;109:1265-1274.
30. Robinson NE. International workshop on equine chronic airway disease. Michigan State University 16-18 June 2000. Equine Vet J 2001;33:5-19.
31. Ainsworth DM, Appleton JA, Antczak DF, et al. IgG anti-body responses to an inhaled antigen in horses with "heaves" (recurrent airway obstruction). Vet Immunol Immunopathol 2002;84:169-180.
32. Joubert P, Silversides DW, Lavoie J-P. Equine neutrophils express mRNA for tumour necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for 1L-4, IL-5 and interferon-γ. Equine Vet J 2001;33:730-733.
33. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets 2006;7:649-660.
34. Walker A, Ward C, Taylor E, et al. Regulation of neutorhil apoptosis and removal of apoptotic cells. Curr Drug Targets - Inflamm Allergy 2005;4:447-454.
35. Art T, Kirschvink N, Smith N, et al. Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Eq Vet J 1999;32:397-401.
36. Lindberg A, Robinson NE, Nasman-Glaser B, et al. Assessment of leukotriene B4 production in leukocytes from horses with recurrent airway obstruction. Am J Vet Res 2004;65:289-295.
37. Caramori G, Adcock I. Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. Curr Drug Targets - Inflamm Allergy 2005;4:455-463.
38. Laan TTJR, Bull S, Pirie R, et al. The role of alveolar macrophages in the pathogenesis of recurrent airway obstruction in horses. J Vet Intern Med 2006;30:167-174.
39. Akira S. IL-6 regulated transcription factors. Int J Biochem Cell Biol 1997;29:1404-1418.
40. Kafoury RM, Hernandez JM, Lasky JA, et al. Activation of transcription factor IL-6 (NF-IL-6) and nuclear factor-κB (NF-κB) by lipid ozonation products is crucial to interleukin-8 gene expression in human airway epithelial cells. Environ Toxicol 2007;22:159-168.
41. Poole JA, Wyatt TA, Von Essen SG, et al. Repeat organic dust exposure-induced monocyte inflammation is associated with protein kinase C activity. J Allergy Clin Immunol 2007;120:366-373.
42. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998;12:221-234.
43. Barnes PJ. Transcription factors in airway diseases. Lab Invest 2006;86:867-872.
44. Trapp JF, Watt JL, Frees KL, et al. The effect of glucocorticoids on grain dust-induced airway disease. Chest 1998;113:505-513.
45. Belvisi MG. Regulation of inflammatory cell function by corticosteroids. Proc Am Thor Soc 2004;1:207-214.
46. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001;70:81-120.
47. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thor Soc 2004;1:345-351.